AI

There have been endless claims that AI will transform patient care, freeing up clinicians to spend time with patients and cutting costs, but many investors are wary of grandiose promises and prefer to hear the truth instead according to a session at the HIMSS & Health 2.0 European Digital Conference.

Australia-based healthcare analytics startup Prospection has announced the opening of its Japan headquarters, and appointment of health informatics and pharmaceutical veteran Kaoru Sato to lead the company’s first global office.

More people experienced high blood pressure in response to the COVID-19 pandemic compared to before, according to new research from chronic care management company Livongo.

The offerings, aimed at improving patient communication, have been developed by intelligent commerce and customer service software provider, Novomind MEA.

A recent survey suggests that patients value knowledge of how exactly their personal information will be used.

The solution answers common questions about COVID-19 in Welsh or English.  

The UK study will enable earlier identification of infection and develop research for treatment.

The AI-integrated software can be used for early detection of COVID-19 and other diseases through imaging biomarkers in Europe.

The AI medical software solution reportedly identifies abnormalities in body fluids and tissues, and is currently able to diagnose eight diseases, including rare genetic disorders.

Dr. Matthew Fradkin, a pediatrician at Swedish Primary Care and Providence St. Joseph, discusses his work implementing an ambient scribe in his workflow at HIMSS20 Digital.